Roger Pomerantz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Roger Pomerantz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Roger Pomerantz. Roger Pomerantz is a Director in Viracta Therapeutics, Inc. ($SNSS) and an Chief Executive Officer in CONTRAFECT Corp ($CFRX) and a Director in CONTRAFECT Corp ($CFRX) and a Director in Seres Therapeutics, Inc. ($MCRB) and a President and CEO in Seres Therapeutics, Inc. ($MCRB) and a Director in Intec Pharma Ltd. ($NTEC) and a Director in Rubius Therapeutics, Inc. ($RUBY).
Address: 711 HARVEST HILL ROAD CHALFONT 18914 PA
Companies in which Roger Pomerantz is an Insider
CONTRAFECT Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Chief Executive Officer, Director
Holdings: 800 shares
Current Value: $1,360
Latest Transaction: Apr 13 2021
$CFRX Market Capitalization: $70.68M
$CFRX Previous Close: $1.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intec Pharma Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Director
Holdings: 0 shares
Latest Transaction: Jul 17 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Rubius Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Roger Pomerantz: Director
Holdings: 100 shares
Latest Transaction: Jul 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Seres Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Director, President and CEO
Holdings: 213,976 shares
Current Value: $2,032,772
Latest Transaction: Jun 14 2019
$MCRB Market Capitalization: $374.90M
$MCRB Previous Close: $9.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Viracta Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Roger Pomerantz: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 30 2021
$SNSS Market Capitalization: $85.18M
$SNSS Previous Close: $4.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Roger Pomerantz
Sentiment: All, CFRX, NTEC, RUBY, MCRB, SNSS
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13 2021 | CFRX | CONTRAFECT Corp | Pomerantz Roger | Chief Executive Off ... | Option Exercise | A | 4.31 | 254,000 | 1,094,740 | 254,000 | |
| Mar 30 2021 | SNSS | Viracta Therapeuti ... | Pomerantz Roger | Director | Option Exercise | A | 8.74 | 135,000 | 1,179,900 | 135,000 | |
| Jul 17 2020 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 0.31 | 40,000 | 12,300 | 40,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jul 02 2019 | NTEC | Intec Pharma Ltd. | Pomerantz Roger | Director | Option Exercise | A | 4.86 | 20,000 | 97,160 | 20,000 | |
| Jun 14 2019 | MCRB | Seres Therapeutics ... | Pomerantz Roger | Director | Option Exercise | A | 2.83 | 15,000 | 42,450 | 15,000 | |
| Sep 11 2018 | MCRB | Seres Therapeutics ... | Pomerantz Roger | President and CEO | Sell | S | 9.00 | 1,810 | 16,291 | 213,976 | 215.8 K to 214 K (-0.84 %) |